138 related articles for article (PubMed ID: 25530226)
1. Were There "Additional Foreseeable Risks" in the SUPPORT Study? Lessons Not Learned from the ARDSnet Clinical Trials.
Silverman HJ; Dreyfuss D
Hastings Cent Rep; 2015; 45(1):21-9. PubMed ID: 25530226
[TBL] [Abstract][Full Text] [Related]
2. SUPPORT and the Ethics of Study Implementation: Lessons for Comparative Effectiveness Research from the Trial of Oxygen Therapy for Premature Babies.
Lantos JD; Feudtner C
Hastings Cent Rep; 2015; 45(1):30-40. PubMed ID: 25530316
[TBL] [Abstract][Full Text] [Related]
3. SUPPORT: Risks, Harms, and Equipoise.
Nelson RM
Hastings Cent Rep; 2015; 45(1):40-2. PubMed ID: 25600385
[No Abstract] [Full Text] [Related]
4. SUPPORT and Comparative Effectiveness Trials: What's at Stake?
Shepherd L
Hastings Cent Rep; 2015; 45(1):44-5. PubMed ID: 25600387
[No Abstract] [Full Text] [Related]
5. Muddled measures of risks and misremembered reasons.
Lantos JD; Feudtner C
Hastings Cent Rep; 2015; 45(3):4-5. PubMed ID: 25944195
[No Abstract] [Full Text] [Related]
6. The author replies.
Nelson RM
Hastings Cent Rep; 2015; 45(3):4. PubMed ID: 25944196
[No Abstract] [Full Text] [Related]
7. What counts as equipoise?
Silverman HJ; Dreyfuss D
Hastings Cent Rep; 2015; 45(3):3-4. PubMed ID: 25944194
[No Abstract] [Full Text] [Related]
8. The Controversy over SUPPORT Continues and the Hyperbole Increases.
Fleischman AR
Hastings Cent Rep; 2015; 45(1):42-4. PubMed ID: 25600386
[No Abstract] [Full Text] [Related]
9. The potential harms and benefits from research on medical practices.
Wilfond BS; Magnus DC
Hastings Cent Rep; 2015; 45(3):5-6. PubMed ID: 25944197
[No Abstract] [Full Text] [Related]
10. Ongoing Controversy over SUPPORT.
Kaebnick GE
Hastings Cent Rep; 2015; 45(1):2. PubMed ID: 25600377
[No Abstract] [Full Text] [Related]
11. Ethical pitfalls in neonatal comparative effectiveness trials.
Modi N
Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
[TBL] [Abstract][Full Text] [Related]
12. Ethical support for surfactant, positive pressure, and oxygenation randomized trial (SUPPORT).
Fanaroff JM
J Pediatr; 2013 Nov; 163(5):1498-9. PubMed ID: 23885963
[No Abstract] [Full Text] [Related]
13. Risk, consent, and SUPPORT.
Magnus D; Caplan AL
N Engl J Med; 2013 May; 368(20):1864-5. PubMed ID: 23597408
[No Abstract] [Full Text] [Related]
14. Foreseeable risks? Informed consent for studies within the standard of care.
Sacks CA; Warren CE
N Engl J Med; 2015 Jan; 372(4):306-7. PubMed ID: 25517574
[No Abstract] [Full Text] [Related]
15. [When the information provided to participants of a comparative effectiveness trial ends up in the court: The opening of Pandora's box?].
Dal-Ré R; Omeñaca F; Gracia D
Med Clin (Barc); 2016 Jul; 147(2):76-80. PubMed ID: 26961391
[No Abstract] [Full Text] [Related]
16. Risks and benefits of comparative effectiveness research in preterm infants: SUPPORT.
Stevenson DK; Wong RJ; Tyson JE
J Comp Eff Res; 2014 Jan; 3(1):17-21. PubMed ID: 24345253
[No Abstract] [Full Text] [Related]
17. The SUPPORT controversy and the debate over research within the standard of care.
Magnus D
Am J Bioeth; 2013; 13(12):1-2. PubMed ID: 24256521
[No Abstract] [Full Text] [Related]
18. What Is Reasonably Foreseeable? Lessons Learned From the SUPPORT Trial.
Trifiletti DM; Showalter TN; Shepherd L
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):718-20. PubMed ID: 26104926
[No Abstract] [Full Text] [Related]
19. OHRP and SUPPORT: lessons in balancing safety and improving the way we care for patients.
Wright CJ; Saugstad OD
J Pediatr; 2013 Nov; 163(5):1495-7. PubMed ID: 24050739
[No Abstract] [Full Text] [Related]
20. An Ethical Analysis of the SUPPORT Trial: Addressing Challenges Posed by a Pragmatic Comparative Effectiveness Randomized Controlled Trial.
Horn AR; Weijer C; Grimshaw J; Brehaut J; Fergusson D; Goldstein CE; Taljaard M
Kennedy Inst Ethics J; 2018; 28(1):85-118. PubMed ID: 29628452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
